A newly filed bill in North Carolina would narrowly legalize medical marijuana, allowing access for individuals enrolled in a “registered research study.”
Titled the Cannabis Treatment Research Act, HB 984 would allow patients and caregivers to register with the state, which in turn would permit legal possession of up to 1.5 ounces of marijuana. It’s sponsored by Rep. Julia Greenfield (D) and five other Democratic lawmakers.
The three-page bill would create a Cannabis Treatment Research Database under the Department of Health and Human Services (DHHS). To qualify for the program, patients would need to be enrolled in a study conducted by a hospital, university, lab, pharmaceutical manufacturer or private medical research company that is registered with DHHS and has entered a study into the state research database.
The legislation specifies no age limit for patients, but registered caregivers would need to be at least 18. As for qualifying conditions, it lists no specific maladies but mandates that patients obtain a signed statement from “a physician with whom the patient has a bona fide physician-patient relationship indicating that, in the physician’s professional opinion, the patient has a medical condition and the potential health benefits of the medical use of cannabis would likely outweigh the health risks for the patient.”
It’s not immediately clear how accessible the research-focused program would be in practice, though it appears that authors intend the program to be relatively open.
The measure states, for example, that it’s the General Assembly’s intent “that any physician who issues a written certification to a patient be permitted to participate in objective scientific research.” It also defines research broadly to include “the development of quality control, purity, and labeling standards for cannabis; sound advice and recommendations on the best practices for the safe and efficient medical use of cannabis; and analysis of genetic and healing properties of the many varied strains of cannabis to determine which strains may be best suited for a particular medical condition or treatment.”
In addition to legalizing possession among registered patients and caregivers, the bill shields from liability both research institutions and their employees. It also specifies that the identities of patients, caregivers and research institutions be shielded from public record, though in some cases it allows records to be provided to law enforcement.
The Democrat-led measure was introduced on Thursday in the House of Representatives. Lawmakers—including Senate President Phil Berger (R)—have said they’re deferring to the House on medical marijuana reform this session, but it’s not clear whether HB 984 is the only bill that will be introduced in that chamber.